Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 09:08 am Purchase |
2021-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
Deep Track Capital, LP | 1,900,000 4.000% |
1,334 (+0.07%) |
Filing History |
| 2022-02-14 09:01 am Sale |
2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Deep Track Capital, LP | 2,450,000 4.000% |
-640,200 (-20.72%) |
Filing History |
| 2022-02-14 09:00 am Sale |
2021-12-31 | 13G | AVROBIO, Inc. AVRO |
Deep Track Capital, LP | 87,511 2.410% |
-96,750 (-52.51%) |
Filing History |
| 2022-02-14 09:00 am Sale |
2021-12-31 | 13G | Repare Therapeutics Inc. RPTX |
Deep Track Capital, LP | 2,100,000 5.030% |
-4,600 (-0.22%) |
Filing History |
| 2022-02-14 08:59 am Purchase |
2021-12-31 | 13G | Passage Bio, Inc. PASG |
Deep Track Capital, LP | 3,216,997 5.950% |
364,057 (+12.76%) |
Filing History |
| 2022-02-14 08:58 am Purchase |
2021-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
Deep Track Capital, LP | 4,870,000 8.290% |
714,445 (+17.19%) |
Filing History |
| 2022-02-14 08:58 am Purchase |
2021-12-31 | 13G | Keros Therapeutics, Inc. KROS |
Deep Track Capital, LP | 1,300,000 5.500% |
11,276 (+0.87%) |
Filing History |
| 2022-02-14 08:57 am Purchase |
2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Deep Track Capital, LP | 1,500,000 6.130% |
233,116 (+18.40%) |
Filing History |
| 2022-02-14 08:56 am Purchase |
2021-12-31 | 13G | Jounce Therapeutics, Inc. JNCE |
Deep Track Capital, LP | 4,000,000 7.810% |
143,537 (+3.72%) |
Filing History |
| 2022-02-14 08:56 am Purchase |
2021-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
Deep Track Capital, LP | 1,900,000 5.910% |
100,000 (+5.56%) |
Filing History |
| 2022-02-14 08:55 am Purchase |
2021-12-31 | 13G | Assembly Biosciences, Inc. ASMB |
Deep Track Capital, LP | 250,000 6.270% |
50,510 (+25.32%) |
Filing History |
| 2022-02-11 5:11 pm Purchase |
2022-02-04 | 13G | Immunovant, Inc. IMVT |
Deep Track Capital, LP | 6,780,827 5.830% |
6,780,827 (New Position) |
Filing History |
| 2022-02-03 9:43 pm Purchase |
2022-01-28 | 13G | Kura Oncology, Inc. KURA |
Deep Track Capital, LP | 3,362,000 5.050% |
3,362,000 (New Position) |
Filing History |
| 2022-01-27 4:35 pm Purchase |
2022-01-24 | 13G | Bicycle Therapeutics plc BCYC |
Deep Track Capital, LP | 1,496,138 5.090% |
1,496,138 (New Position) |
Filing History |
| 2022-01-27 4:34 pm Purchase |
2022-01-24 | 13G | Acumen Pharmaceuticals, Inc. ABOS |
Deep Track Capital, LP | 2,414,917 5.970% |
2,414,917 (New Position) |
Filing History |
| 2022-01-20 4:27 pm Purchase |
2022-01-18 | 13G | Dyne Therapeutics, Inc. DYN |
Deep Track Capital, LP | 2,816,950 5.470% |
2,816,950 (New Position) |
Filing History |
| 2021-12-30 4:37 pm Purchase |
2021-12-29 | 13G | Keros Therapeutics, Inc. KROS |
Deep Track Capital, LP | 1,288,724 5.450% |
1,288,724 (New Position) |
Filing History |
| 2021-12-09 4:54 pm Purchase |
2021-12-03 | 13G | Esperion Therapeutics, Inc. ESPR |
Deep Track Capital, LP | 6,345,790 9.990% |
6,345,790 (New Position) |
Filing History |
| 2021-11-17 4:11 pm Purchase |
2021-11-15 | 13G | TRICIDA INC TCDAQ |
Deep Track Capital, LP | 5,857,829 9.990% |
5,857,829 (New Position) |
Filing History |
| 2021-11-04 5:02 pm Purchase |
2021-10-29 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
Deep Track Capital, LP | 1,800,000 5.690% |
1,800,000 (New Position) |
Filing History |